Successful use of Remcyte®-based continuous hemodiafiltration in a case of refractory CRS and ICANS complicated by tumor lysis syndrome–associated AKI | Synapse
March 3, 2026
Successful use of Remcyte®-based continuous hemodiafiltration in a case of refractory CRS and ICANS complicated by tumor lysis syndrome–associated AKI
Key Points
Effective use of Remcyte® in managing acute kidney injury related to tumor lysis syndrome.
Management included continuous hemodiafiltration, leading to improved patient status.
This case highlights the potential of hemodialysis in treating refractory chronic respiratory syndrome.
Indicates a need for further exploration of Remcyte® in similar acute conditions.